Genetic diversity of a Korean echovirus 5 isolate and response of the strain to five antiviral drugs

An outbreak of echovirus 5 (ECV 5) occurred in Korea in 2006, marking the first time this virus had been identified in the country since enterovirus surveillance began in 1993. Using a sample isolated from a young male patient with aseptic meningitis, we performed sequencing of the Korean ECV 5 stra...

Full description

Bibliographic Details
Main Authors: Park, Kwisung, Song, Jaehyoung, Baek, Kyoungah, Lee, Changgyun, Kim, Donguk, Cho, SamHyun, Park, JoonSoo, Choi, YoungJin, Kang, Byunghak, Choi, Hwajung, Cheon, Doo-Sung
Format: Online
Language:English
Published: BioMed Central 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058091/
id pubmed-3058091
recordtype oai_dc
spelling pubmed-30580912011-03-18 Genetic diversity of a Korean echovirus 5 isolate and response of the strain to five antiviral drugs Park, Kwisung Song, Jaehyoung Baek, Kyoungah Lee, Changgyun Kim, Donguk Cho, SamHyun Park, JoonSoo Choi, YoungJin Kang, Byunghak Choi, Hwajung Cheon, Doo-Sung Short Report An outbreak of echovirus 5 (ECV 5) occurred in Korea in 2006, marking the first time this virus had been identified in the country since enterovirus surveillance began in 1993. Using a sample isolated from a young male patient with aseptic meningitis, we performed sequencing of the Korean ECV 5 strain and compared it with a prototype strain (Noyce). At the nucleotide level, the P1 region (85.3%) had the highest identity value; at the amino acid level, the P3 region (98.0%) had the highest identity value. The two strains shared all cleavage sites, with the exception of the VP1/2A site, which was TY/GA in the Noyce strain but TR/GA in the Korean ECV 5 isolate. In Vero cells infected with the Korean ECV 5 isolate, no cytotoxicity was observed in the presence of azidothymidine, acyclovir, amantadine, lamivudine, or ribavirin, when the drugs were administered at a CC50 value >100 μg/mL. Of the five drugs, only amantadine (IC50: 1 ± 0.42 μg/mL, TI: 100) and ribavirin (IC50: 22 ± 1.36 μg/mL, TI: 4.55) had any antiviral activity against the Korean ECV 5 isolate. BioMed Central 2011-02-24 /pmc/articles/PMC3058091/ /pubmed/21345236 http://dx.doi.org/10.1186/1743-422X-8-79 Text en Copyright ©2011 Park et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Park, Kwisung
Song, Jaehyoung
Baek, Kyoungah
Lee, Changgyun
Kim, Donguk
Cho, SamHyun
Park, JoonSoo
Choi, YoungJin
Kang, Byunghak
Choi, Hwajung
Cheon, Doo-Sung
spellingShingle Park, Kwisung
Song, Jaehyoung
Baek, Kyoungah
Lee, Changgyun
Kim, Donguk
Cho, SamHyun
Park, JoonSoo
Choi, YoungJin
Kang, Byunghak
Choi, Hwajung
Cheon, Doo-Sung
Genetic diversity of a Korean echovirus 5 isolate and response of the strain to five antiviral drugs
author_facet Park, Kwisung
Song, Jaehyoung
Baek, Kyoungah
Lee, Changgyun
Kim, Donguk
Cho, SamHyun
Park, JoonSoo
Choi, YoungJin
Kang, Byunghak
Choi, Hwajung
Cheon, Doo-Sung
author_sort Park, Kwisung
title Genetic diversity of a Korean echovirus 5 isolate and response of the strain to five antiviral drugs
title_short Genetic diversity of a Korean echovirus 5 isolate and response of the strain to five antiviral drugs
title_full Genetic diversity of a Korean echovirus 5 isolate and response of the strain to five antiviral drugs
title_fullStr Genetic diversity of a Korean echovirus 5 isolate and response of the strain to five antiviral drugs
title_full_unstemmed Genetic diversity of a Korean echovirus 5 isolate and response of the strain to five antiviral drugs
title_sort genetic diversity of a korean echovirus 5 isolate and response of the strain to five antiviral drugs
description An outbreak of echovirus 5 (ECV 5) occurred in Korea in 2006, marking the first time this virus had been identified in the country since enterovirus surveillance began in 1993. Using a sample isolated from a young male patient with aseptic meningitis, we performed sequencing of the Korean ECV 5 strain and compared it with a prototype strain (Noyce). At the nucleotide level, the P1 region (85.3%) had the highest identity value; at the amino acid level, the P3 region (98.0%) had the highest identity value. The two strains shared all cleavage sites, with the exception of the VP1/2A site, which was TY/GA in the Noyce strain but TR/GA in the Korean ECV 5 isolate. In Vero cells infected with the Korean ECV 5 isolate, no cytotoxicity was observed in the presence of azidothymidine, acyclovir, amantadine, lamivudine, or ribavirin, when the drugs were administered at a CC50 value >100 μg/mL. Of the five drugs, only amantadine (IC50: 1 ± 0.42 μg/mL, TI: 100) and ribavirin (IC50: 22 ± 1.36 μg/mL, TI: 4.55) had any antiviral activity against the Korean ECV 5 isolate.
publisher BioMed Central
publishDate 2011
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058091/
_version_ 1611445684052951040